CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
1,913.00
-3.00 (-0.16%)
Sep 17, 2025, 3:30 PM KST
CMG Pharmaceutical Revenue
CMG Pharmaceutical had revenue of 22.67B KRW in the quarter ending June 30, 2025, a decrease of -8.79%. This brings the company's revenue in the last twelve months to 94.73B, up 1.65% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.
Revenue (ttm)
94.73B
Revenue Growth
+1.65%
P/S Ratio
2.98
Revenue / Employee
424.78M
Employees
223
Market Cap
282.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
Dec 31, 2018 | 49.86B | 8.33B | 20.05% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |